· Venture Capital Tracker · investment-strategies  · 1 min read

Anthropic's $30B Series G: Frontier AI Valuations Follow Enterprise Pull

Anthropic's jump to a reported $380B valuation reflects investor belief that enterprise AI revenue concentration will intensify.

Anthropic's jump to a reported $380B valuation reflects investor belief that enterprise AI revenue concentration will intensify.

VCT data record

Funding event facts

Source-backed financing and transaction details. Unknown terms remain undisclosed rather than estimated.

Anthropic raises $30B Series G at a $380B valuation

Event type
Funding Round
Event date
Feb 12, 2026
Stage / label
Series G
Amount
$30B
Valuation
$380B
Confidence
Company Disclosed

Company / target: Anthropic

Sources: anthropic.com

Anthropic announced $30 billion Series G in 2026 ($380B post-money valuation).

The problem this startup is attacking

Enterprises need reliable, policy-safe AI systems for production workflows with auditable behavior and support.

Why this is a live problem now

Large buyers are selecting long-term model vendors, making platform lock-in and trust features economically decisive.

Competitive map

OpenAI, Google, xAI, Mistral and enterprise-focused open model alternatives.

Market signal (the number to remember)

  • Gartner forecasts global GenAI spending at $644B in 2025, up 76.4% YoY.

Practical takeaway (operator + investor)

If you are building in this category, optimize for measurable production outcomes (latency, reliability, unit economics, or risk reduction), not feature novelty. In 2026, capital is concentrating behind teams that can turn technical advantage into repeatable operating performance.

Sources

  1. Primary coverage: https://techcrunch.com/2026/02/12/anthropic-raises-another-30-billion-in-series-g-with-a-new-value-of-380-billion
  2. Market data: https://www.gartner.com/en/newsroom/press-releases/2025-03-31-gartner-forecasts-worldwide-genai-spending-to-reach-644-billion-in-2025

Follow Venture Capital Tracker in Google

Add VCT as a preferred source to make our venture-capital coverage easier to find in Google Search.

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Research the entities in this story

Persistent profiles connect this article to the companies and investors it discusses.

Back to Blog

Recommended next

Browse all research »

How Much Did AusperBio Raise? $120M Series C, No Valuation

AusperBio closed a $120 million Series C on August 27, 2026. An unnamed strategic investor led. RA Capital joined. The company cites $360 million raised since 2024. Valuation was not disclosed. AHB-137 is in Phase 3 in China and remains investigational.